NCT04918121View on ClinicalTrials.gov

A Study of Yutiq Steroid Insert During Glaucoma Tube Implant Surgery

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Glaucoma

Interventions

DRUG

Yutiq 0.18 MG Drug Implant

a sustained-release steroid insert (Yutiq)

Trial Locations (1)

27710

Duke Eye Center, Durham

All Listed Sponsors

lead

Sanjay Asrani

OTHER